nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ALB—Captopril—systemic scleroderma	0.0718	0.129	CbGbCtD
Clomipramine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0574	0.103	CbGbCtD
Clomipramine—ALB—Mycophenolate mofetil—systemic scleroderma	0.0565	0.101	CbGbCtD
Clomipramine—CYP1A2—Leflunomide—systemic scleroderma	0.0548	0.0982	CbGbCtD
Clomipramine—ABCB1—Lisinopril—systemic scleroderma	0.0502	0.09	CbGbCtD
Clomipramine—ALB—Prednisone—systemic scleroderma	0.0452	0.081	CbGbCtD
Clomipramine—ABCB1—Captopril—systemic scleroderma	0.0376	0.0673	CbGbCtD
Clomipramine—CYP2D6—Captopril—systemic scleroderma	0.0354	0.0635	CbGbCtD
Clomipramine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0296	0.053	CbGbCtD
Clomipramine—CYP2C19—Prednisone—systemic scleroderma	0.0293	0.0525	CbGbCtD
Clomipramine—ABCB1—Prednisone—systemic scleroderma	0.0236	0.0424	CbGbCtD
Clomipramine—HTR2B—cardial valve—systemic scleroderma	0.0232	0.326	CbGeAlD
Clomipramine—ALB—Methotrexate—systemic scleroderma	0.0227	0.0407	CbGbCtD
Clomipramine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0177	0.0318	CbGbCtD
Clomipramine—CYP3A4—Prednisone—systemic scleroderma	0.0142	0.0254	CbGbCtD
Clomipramine—ABCB1—Methotrexate—systemic scleroderma	0.0119	0.0213	CbGbCtD
Clomipramine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00707	0.0997	CbGeAlD
Clomipramine—HTR2A—pulmonary artery—systemic scleroderma	0.005	0.0706	CbGeAlD
Clomipramine—HRH2—skin of body—systemic scleroderma	0.00211	0.0298	CbGeAlD
Clomipramine—HTR2A—artery—systemic scleroderma	0.00186	0.0262	CbGeAlD
Clomipramine—HRH2—digestive system—systemic scleroderma	0.00169	0.0238	CbGeAlD
Clomipramine—GSTP1—connective tissue—systemic scleroderma	0.00168	0.0237	CbGeAlD
Clomipramine—HTR2A—endothelium—systemic scleroderma	0.00157	0.0221	CbGeAlD
Clomipramine—GSTP1—smooth muscle tissue—systemic scleroderma	0.00154	0.0217	CbGeAlD
Clomipramine—GSTP1—skin of body—systemic scleroderma	0.00152	0.0214	CbGeAlD
Clomipramine—HTR2A—blood vessel—systemic scleroderma	0.00145	0.0204	CbGeAlD
Clomipramine—HRH2—lung—systemic scleroderma	0.00141	0.0199	CbGeAlD
Clomipramine—HTR2B—smooth muscle tissue—systemic scleroderma	0.00127	0.0179	CbGeAlD
Clomipramine—HTR2B—skin of body—systemic scleroderma	0.00125	0.0177	CbGeAlD
Clomipramine—GSTP1—digestive system—systemic scleroderma	0.00122	0.0171	CbGeAlD
Clomipramine—GSTP1—tendon—systemic scleroderma	0.00116	0.0163	CbGeAlD
Clomipramine—GSTP1—lung—systemic scleroderma	0.00102	0.0143	CbGeAlD
Clomipramine—SLC6A4—digestive system—systemic scleroderma	0.00101	0.0143	CbGeAlD
Clomipramine—HTR2B—digestive system—systemic scleroderma	0.001	0.0141	CbGeAlD
Clomipramine—HTR2B—tendon—systemic scleroderma	0.000954	0.0134	CbGeAlD
Clomipramine—ABCB1—blood vessel—systemic scleroderma	0.000947	0.0134	CbGeAlD
Clomipramine—ADRA2A—connective tissue—systemic scleroderma	0.000871	0.0123	CbGeAlD
Clomipramine—SLC6A4—lung—systemic scleroderma	0.000845	0.0119	CbGeAlD
Clomipramine—CYP2C19—digestive system—systemic scleroderma	0.000838	0.0118	CbGeAlD
Clomipramine—HTR2B—lung—systemic scleroderma	0.000837	0.0118	CbGeAlD
Clomipramine—SLC6A2—lung—systemic scleroderma	0.000744	0.0105	CbGeAlD
Clomipramine—HTR2A—connective tissue—systemic scleroderma	0.000741	0.0104	CbGeAlD
Clomipramine—CYP1A2—digestive system—systemic scleroderma	0.000685	0.00965	CbGeAlD
Clomipramine—HTR2A—smooth muscle tissue—systemic scleroderma	0.000678	0.00956	CbGeAlD
Clomipramine—ADRA2A—tendon—systemic scleroderma	0.000599	0.00845	CbGeAlD
Clomipramine—CYP1A2—lung—systemic scleroderma	0.000572	0.00806	CbGeAlD
Clomipramine—HTR2A—digestive system—systemic scleroderma	0.000535	0.00755	CbGeAlD
Clomipramine—ADRA2A—lung—systemic scleroderma	0.000526	0.00741	CbGeAlD
Clomipramine—HTR2A—tendon—systemic scleroderma	0.000509	0.00718	CbGeAlD
Clomipramine—CYP3A4—digestive system—systemic scleroderma	0.000495	0.00699	CbGeAlD
Clomipramine—CYP2D6—digestive system—systemic scleroderma	0.000488	0.00687	CbGeAlD
Clomipramine—HTR2A—lung—systemic scleroderma	0.000447	0.0063	CbGeAlD
Clomipramine—ABCB1—digestive system—systemic scleroderma	0.000351	0.00495	CbGeAlD
Clomipramine—ABCB1—lung—systemic scleroderma	0.000293	0.00413	CbGeAlD
Clomipramine—Hypotension—Lisinopril—systemic scleroderma	0.000145	0.000391	CcSEcCtD
Clomipramine—Dizziness—Captopril—systemic scleroderma	0.000145	0.00039	CcSEcCtD
Clomipramine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000389	CcSEcCtD
Clomipramine—Depression—Prednisone—systemic scleroderma	0.000144	0.000388	CcSEcCtD
Clomipramine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000388	CcSEcCtD
Clomipramine—Urticaria—Leflunomide—systemic scleroderma	0.000144	0.000387	CcSEcCtD
Clomipramine—Abdominal pain—Leflunomide—systemic scleroderma	0.000143	0.000385	CcSEcCtD
Clomipramine—Body temperature increased—Leflunomide—systemic scleroderma	0.000143	0.000385	CcSEcCtD
Clomipramine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000142	0.000384	CcSEcCtD
Clomipramine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000142	0.000383	CcSEcCtD
Clomipramine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000382	CcSEcCtD
Clomipramine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000382	CcSEcCtD
Clomipramine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000382	CcSEcCtD
Clomipramine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000142	0.000382	CcSEcCtD
Clomipramine—Myocardial infarction—Prednisone—systemic scleroderma	0.000142	0.000382	CcSEcCtD
Clomipramine—Breast disorder—Methotrexate—systemic scleroderma	0.000142	0.000382	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000141	0.000381	CcSEcCtD
Clomipramine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000381	CcSEcCtD
Clomipramine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000141	0.00038	CcSEcCtD
Clomipramine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000141	0.00038	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00038	CcSEcCtD
Clomipramine—Insomnia—Lisinopril—systemic scleroderma	0.00014	0.000378	CcSEcCtD
Clomipramine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000378	CcSEcCtD
Clomipramine—Paraesthesia—Lisinopril—systemic scleroderma	0.000139	0.000375	CcSEcCtD
Clomipramine—Vomiting—Captopril—systemic scleroderma	0.000139	0.000375	CcSEcCtD
Clomipramine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000374	CcSEcCtD
Clomipramine—Dyspnoea—Lisinopril—systemic scleroderma	0.000138	0.000373	CcSEcCtD
Clomipramine—Rash—Captopril—systemic scleroderma	0.000138	0.000372	CcSEcCtD
Clomipramine—Dermatitis—Captopril—systemic scleroderma	0.000138	0.000372	CcSEcCtD
Clomipramine—Somnolence—Lisinopril—systemic scleroderma	0.000138	0.000372	CcSEcCtD
Clomipramine—Headache—Captopril—systemic scleroderma	0.000137	0.00037	CcSEcCtD
Clomipramine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000369	CcSEcCtD
Clomipramine—Dyspepsia—Lisinopril—systemic scleroderma	0.000137	0.000368	CcSEcCtD
Clomipramine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000136	0.000367	CcSEcCtD
Clomipramine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000136	0.000367	CcSEcCtD
Clomipramine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000366	CcSEcCtD
Clomipramine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000366	CcSEcCtD
Clomipramine—Decreased appetite—Lisinopril—systemic scleroderma	0.000135	0.000363	CcSEcCtD
Clomipramine—Eosinophilia—Methotrexate—systemic scleroderma	0.000134	0.000361	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000134	0.000361	CcSEcCtD
Clomipramine—Fatigue—Lisinopril—systemic scleroderma	0.000134	0.00036	CcSEcCtD
Clomipramine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000134	0.00036	CcSEcCtD
Clomipramine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000359	CcSEcCtD
Clomipramine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000359	CcSEcCtD
Clomipramine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000133	0.000359	CcSEcCtD
Clomipramine—Pain—Lisinopril—systemic scleroderma	0.000133	0.000358	CcSEcCtD
Clomipramine—Constipation—Lisinopril—systemic scleroderma	0.000133	0.000358	CcSEcCtD
Clomipramine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000358	CcSEcCtD
Clomipramine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000356	CcSEcCtD
Clomipramine—Bradycardia—Prednisone—systemic scleroderma	0.000132	0.000356	CcSEcCtD
Clomipramine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000354	CcSEcCtD
Clomipramine—Diarrhoea—Azathioprine—systemic scleroderma	0.000131	0.000353	CcSEcCtD
Clomipramine—Nausea—Captopril—systemic scleroderma	0.00013	0.000351	CcSEcCtD
Clomipramine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000349	CcSEcCtD
Clomipramine—Asthenia—Leflunomide—systemic scleroderma	0.00013	0.000349	CcSEcCtD
Clomipramine—Hallucination—Prednisone—systemic scleroderma	0.000129	0.000348	CcSEcCtD
Clomipramine—Pancytopenia—Methotrexate—systemic scleroderma	0.000129	0.000347	CcSEcCtD
Clomipramine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000128	0.000345	CcSEcCtD
Clomipramine—Pruritus—Leflunomide—systemic scleroderma	0.000128	0.000344	CcSEcCtD
Clomipramine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000128	0.000343	CcSEcCtD
Clomipramine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000342	CcSEcCtD
Clomipramine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000127	0.000342	CcSEcCtD
Clomipramine—Dysuria—Methotrexate—systemic scleroderma	0.000127	0.000341	CcSEcCtD
Clomipramine—Dizziness—Azathioprine—systemic scleroderma	0.000126	0.000341	CcSEcCtD
Clomipramine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000125	0.000336	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000334	CcSEcCtD
Clomipramine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000124	0.000333	CcSEcCtD
Clomipramine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000124	0.000333	CcSEcCtD
Clomipramine—Diarrhoea—Leflunomide—systemic scleroderma	0.000124	0.000333	CcSEcCtD
Clomipramine—Urticaria—Lisinopril—systemic scleroderma	0.000123	0.000332	CcSEcCtD
Clomipramine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000331	CcSEcCtD
Clomipramine—Abdominal pain—Lisinopril—systemic scleroderma	0.000123	0.000331	CcSEcCtD
Clomipramine—Body temperature increased—Lisinopril—systemic scleroderma	0.000123	0.000331	CcSEcCtD
Clomipramine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000329	CcSEcCtD
Clomipramine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000122	0.000328	CcSEcCtD
Clomipramine—Vomiting—Azathioprine—systemic scleroderma	0.000122	0.000328	CcSEcCtD
Clomipramine—Pneumonia—Methotrexate—systemic scleroderma	0.000121	0.000327	CcSEcCtD
Clomipramine—Eye disorder—Prednisone—systemic scleroderma	0.000121	0.000327	CcSEcCtD
Clomipramine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000327	CcSEcCtD
Clomipramine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000326	CcSEcCtD
Clomipramine—Drowsiness—Methotrexate—systemic scleroderma	0.000121	0.000325	CcSEcCtD
Clomipramine—Rash—Azathioprine—systemic scleroderma	0.000121	0.000325	CcSEcCtD
Clomipramine—Dermatitis—Azathioprine—systemic scleroderma	0.00012	0.000325	CcSEcCtD
Clomipramine—Depression—Methotrexate—systemic scleroderma	0.00012	0.000324	CcSEcCtD
Clomipramine—Flushing—Prednisone—systemic scleroderma	0.00012	0.000324	CcSEcCtD
Clomipramine—Headache—Azathioprine—systemic scleroderma	0.00012	0.000323	CcSEcCtD
Clomipramine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000322	CcSEcCtD
Clomipramine—Dizziness—Leflunomide—systemic scleroderma	0.000119	0.000322	CcSEcCtD
Clomipramine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000318	CcSEcCtD
Clomipramine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000118	0.000318	CcSEcCtD
Clomipramine—Angiopathy—Prednisone—systemic scleroderma	0.000118	0.000317	CcSEcCtD
Clomipramine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000117	0.000316	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000316	CcSEcCtD
Clomipramine—Immune system disorder—Prednisone—systemic scleroderma	0.000117	0.000316	CcSEcCtD
Clomipramine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000313	CcSEcCtD
Clomipramine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000313	CcSEcCtD
Clomipramine—Arrhythmia—Prednisone—systemic scleroderma	0.000116	0.000312	CcSEcCtD
Clomipramine—Sweating—Methotrexate—systemic scleroderma	0.000116	0.000312	CcSEcCtD
Clomipramine—Haematuria—Methotrexate—systemic scleroderma	0.000115	0.00031	CcSEcCtD
Clomipramine—Vomiting—Leflunomide—systemic scleroderma	0.000115	0.000309	CcSEcCtD
Clomipramine—Alopecia—Prednisone—systemic scleroderma	0.000115	0.000309	CcSEcCtD
Clomipramine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000114	0.000308	CcSEcCtD
Clomipramine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000114	0.000308	CcSEcCtD
Clomipramine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000114	0.000307	CcSEcCtD
Clomipramine—Epistaxis—Methotrexate—systemic scleroderma	0.000114	0.000307	CcSEcCtD
Clomipramine—Rash—Leflunomide—systemic scleroderma	0.000114	0.000307	CcSEcCtD
Clomipramine—Dermatitis—Leflunomide—systemic scleroderma	0.000114	0.000307	CcSEcCtD
Clomipramine—Mental disorder—Prednisone—systemic scleroderma	0.000114	0.000306	CcSEcCtD
Clomipramine—Nausea—Azathioprine—systemic scleroderma	0.000114	0.000306	CcSEcCtD
Clomipramine—Headache—Leflunomide—systemic scleroderma	0.000113	0.000305	CcSEcCtD
Clomipramine—Malnutrition—Prednisone—systemic scleroderma	0.000113	0.000304	CcSEcCtD
Clomipramine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000113	0.000304	CcSEcCtD
Clomipramine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000302	CcSEcCtD
Clomipramine—Asthenia—Lisinopril—systemic scleroderma	0.000111	0.0003	CcSEcCtD
Clomipramine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000111	0.0003	CcSEcCtD
Clomipramine—Pruritus—Lisinopril—systemic scleroderma	0.00011	0.000296	CcSEcCtD
Clomipramine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00011	0.000295	CcSEcCtD
Clomipramine—Rash—Mycophenolic acid—systemic scleroderma	0.000109	0.000293	CcSEcCtD
Clomipramine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000109	0.000292	CcSEcCtD
Clomipramine—Hepatitis—Methotrexate—systemic scleroderma	0.000108	0.000292	CcSEcCtD
Clomipramine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000291	CcSEcCtD
Clomipramine—Headache—Mycophenolic acid—systemic scleroderma	0.000108	0.000291	CcSEcCtD
Clomipramine—Pharyngitis—Methotrexate—systemic scleroderma	0.000108	0.00029	CcSEcCtD
Clomipramine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000108	0.00029	CcSEcCtD
Clomipramine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000108	0.00029	CcSEcCtD
Clomipramine—Nausea—Leflunomide—systemic scleroderma	0.000107	0.000289	CcSEcCtD
Clomipramine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000107	0.000288	CcSEcCtD
Clomipramine—Vision blurred—Prednisone—systemic scleroderma	0.000106	0.000287	CcSEcCtD
Clomipramine—Urethral disorder—Methotrexate—systemic scleroderma	0.000106	0.000286	CcSEcCtD
Clomipramine—Diarrhoea—Lisinopril—systemic scleroderma	0.000106	0.000286	CcSEcCtD
Clomipramine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000105	0.000282	CcSEcCtD
Clomipramine—Visual impairment—Methotrexate—systemic scleroderma	0.000105	0.000282	CcSEcCtD
Clomipramine—Anaemia—Prednisone—systemic scleroderma	0.000104	0.000281	CcSEcCtD
Clomipramine—Agitation—Prednisone—systemic scleroderma	0.000104	0.00028	CcSEcCtD
Clomipramine—Dizziness—Lisinopril—systemic scleroderma	0.000103	0.000276	CcSEcCtD
Clomipramine—Nausea—Mycophenolic acid—systemic scleroderma	0.000102	0.000276	CcSEcCtD
Clomipramine—Malaise—Prednisone—systemic scleroderma	0.000102	0.000274	CcSEcCtD
Clomipramine—Vertigo—Prednisone—systemic scleroderma	0.000101	0.000273	CcSEcCtD
Clomipramine—Eye disorder—Methotrexate—systemic scleroderma	0.000101	0.000273	CcSEcCtD
Clomipramine—Syncope—Prednisone—systemic scleroderma	0.000101	0.000273	CcSEcCtD
Clomipramine—Tinnitus—Methotrexate—systemic scleroderma	0.000101	0.000272	CcSEcCtD
Clomipramine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000101	0.000271	CcSEcCtD
Clomipramine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00027	CcSEcCtD
Clomipramine—Loss of consciousness—Prednisone—systemic scleroderma	9.93e-05	0.000267	CcSEcCtD
Clomipramine—Vomiting—Lisinopril—systemic scleroderma	9.87e-05	0.000266	CcSEcCtD
Clomipramine—Angiopathy—Methotrexate—systemic scleroderma	9.84e-05	0.000265	CcSEcCtD
Clomipramine—Immune system disorder—Methotrexate—systemic scleroderma	9.79e-05	0.000264	CcSEcCtD
Clomipramine—Rash—Lisinopril—systemic scleroderma	9.79e-05	0.000264	CcSEcCtD
Clomipramine—Convulsion—Prednisone—systemic scleroderma	9.79e-05	0.000264	CcSEcCtD
Clomipramine—Dermatitis—Lisinopril—systemic scleroderma	9.78e-05	0.000263	CcSEcCtD
Clomipramine—Mediastinal disorder—Methotrexate—systemic scleroderma	9.77e-05	0.000263	CcSEcCtD
Clomipramine—Asthenia—Mycophenolate mofetil—systemic scleroderma	9.76e-05	0.000263	CcSEcCtD
Clomipramine—Hypertension—Prednisone—systemic scleroderma	9.75e-05	0.000263	CcSEcCtD
Clomipramine—Chills—Methotrexate—systemic scleroderma	9.73e-05	0.000262	CcSEcCtD
Clomipramine—Headache—Lisinopril—systemic scleroderma	9.72e-05	0.000262	CcSEcCtD
Clomipramine—Pruritus—Mycophenolate mofetil—systemic scleroderma	9.62e-05	0.000259	CcSEcCtD
Clomipramine—Arthralgia—Prednisone—systemic scleroderma	9.62e-05	0.000259	CcSEcCtD
Clomipramine—Myalgia—Prednisone—systemic scleroderma	9.62e-05	0.000259	CcSEcCtD
Clomipramine—Anxiety—Prednisone—systemic scleroderma	9.58e-05	0.000258	CcSEcCtD
Clomipramine—Alopecia—Methotrexate—systemic scleroderma	9.58e-05	0.000258	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	9.55e-05	0.000257	CcSEcCtD
Clomipramine—Discomfort—Prednisone—systemic scleroderma	9.5e-05	0.000256	CcSEcCtD
Clomipramine—Mental disorder—Methotrexate—systemic scleroderma	9.5e-05	0.000256	CcSEcCtD
Clomipramine—Malnutrition—Methotrexate—systemic scleroderma	9.44e-05	0.000254	CcSEcCtD
Clomipramine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	9.3e-05	0.000251	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—systemic scleroderma	9.24e-05	0.000249	CcSEcCtD
Clomipramine—Nausea—Lisinopril—systemic scleroderma	9.22e-05	0.000248	CcSEcCtD
Clomipramine—Anaphylactic shock—Prednisone—systemic scleroderma	9.22e-05	0.000248	CcSEcCtD
Clomipramine—Oedema—Prednisone—systemic scleroderma	9.22e-05	0.000248	CcSEcCtD
Clomipramine—Back pain—Methotrexate—systemic scleroderma	9.13e-05	0.000246	CcSEcCtD
Clomipramine—Shock—Prednisone—systemic scleroderma	9.07e-05	0.000244	CcSEcCtD
Clomipramine—Nervous system disorder—Prednisone—systemic scleroderma	9.04e-05	0.000244	CcSEcCtD
Clomipramine—Tachycardia—Prednisone—systemic scleroderma	9e-05	0.000242	CcSEcCtD
Clomipramine—Dizziness—Mycophenolate mofetil—systemic scleroderma	8.99e-05	0.000242	CcSEcCtD
Clomipramine—Skin disorder—Prednisone—systemic scleroderma	8.95e-05	0.000241	CcSEcCtD
Clomipramine—Hyperhidrosis—Prednisone—systemic scleroderma	8.91e-05	0.00024	CcSEcCtD
Clomipramine—Vision blurred—Methotrexate—systemic scleroderma	8.9e-05	0.00024	CcSEcCtD
Clomipramine—Anorexia—Prednisone—systemic scleroderma	8.79e-05	0.000237	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—systemic scleroderma	8.76e-05	0.000236	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—systemic scleroderma	8.72e-05	0.000235	CcSEcCtD
Clomipramine—Vomiting—Mycophenolate mofetil—systemic scleroderma	8.65e-05	0.000233	CcSEcCtD
Clomipramine—Rash—Mycophenolate mofetil—systemic scleroderma	8.57e-05	0.000231	CcSEcCtD
Clomipramine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	8.57e-05	0.000231	CcSEcCtD
Clomipramine—Headache—Mycophenolate mofetil—systemic scleroderma	8.52e-05	0.00023	CcSEcCtD
Clomipramine—Malaise—Methotrexate—systemic scleroderma	8.51e-05	0.000229	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—systemic scleroderma	8.48e-05	0.000228	CcSEcCtD
Clomipramine—Leukopenia—Methotrexate—systemic scleroderma	8.45e-05	0.000228	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	8.4e-05	0.000226	CcSEcCtD
Clomipramine—Insomnia—Prednisone—systemic scleroderma	8.34e-05	0.000225	CcSEcCtD
Clomipramine—Paraesthesia—Prednisone—systemic scleroderma	8.28e-05	0.000223	CcSEcCtD
Clomipramine—Cough—Methotrexate—systemic scleroderma	8.24e-05	0.000222	CcSEcCtD
Clomipramine—Convulsion—Methotrexate—systemic scleroderma	8.18e-05	0.00022	CcSEcCtD
Clomipramine—Dyspepsia—Prednisone—systemic scleroderma	8.11e-05	0.000219	CcSEcCtD
Clomipramine—Nausea—Mycophenolate mofetil—systemic scleroderma	8.08e-05	0.000218	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—systemic scleroderma	8.04e-05	0.000216	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—systemic scleroderma	8.04e-05	0.000216	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—systemic scleroderma	8.04e-05	0.000216	CcSEcCtD
Clomipramine—Decreased appetite—Prednisone—systemic scleroderma	8.01e-05	0.000216	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	7.98e-05	0.000215	CcSEcCtD
Clomipramine—Fatigue—Prednisone—systemic scleroderma	7.95e-05	0.000214	CcSEcCtD
Clomipramine—Discomfort—Methotrexate—systemic scleroderma	7.94e-05	0.000214	CcSEcCtD
Clomipramine—Constipation—Prednisone—systemic scleroderma	7.88e-05	0.000212	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—systemic scleroderma	7.77e-05	0.000209	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—systemic scleroderma	7.7e-05	0.000208	CcSEcCtD
Clomipramine—Feeling abnormal—Prednisone—systemic scleroderma	7.6e-05	0.000205	CcSEcCtD
Clomipramine—Nervous system disorder—Methotrexate—systemic scleroderma	7.56e-05	0.000204	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—systemic scleroderma	7.54e-05	0.000203	CcSEcCtD
Clomipramine—Gastrointestinal pain—Prednisone—systemic scleroderma	7.54e-05	0.000203	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—systemic scleroderma	7.48e-05	0.000202	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—systemic scleroderma	7.45e-05	0.000201	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—systemic scleroderma	7.34e-05	0.000198	CcSEcCtD
Clomipramine—Urticaria—Prednisone—systemic scleroderma	7.32e-05	0.000197	CcSEcCtD
Clomipramine—Body temperature increased—Prednisone—systemic scleroderma	7.29e-05	0.000196	CcSEcCtD
Clomipramine—Abdominal pain—Prednisone—systemic scleroderma	7.29e-05	0.000196	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—systemic scleroderma	7.2e-05	0.000194	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.02e-05	0.000189	CcSEcCtD
Clomipramine—Insomnia—Methotrexate—systemic scleroderma	6.97e-05	0.000188	CcSEcCtD
Clomipramine—Paraesthesia—Methotrexate—systemic scleroderma	6.92e-05	0.000186	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—systemic scleroderma	6.87e-05	0.000185	CcSEcCtD
Clomipramine—Somnolence—Methotrexate—systemic scleroderma	6.85e-05	0.000184	CcSEcCtD
Clomipramine—Hypersensitivity—Prednisone—systemic scleroderma	6.79e-05	0.000183	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—systemic scleroderma	6.78e-05	0.000183	CcSEcCtD
Clomipramine—Decreased appetite—Methotrexate—systemic scleroderma	6.7e-05	0.00018	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	6.65e-05	0.000179	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—systemic scleroderma	6.64e-05	0.000179	CcSEcCtD
Clomipramine—Asthenia—Prednisone—systemic scleroderma	6.61e-05	0.000178	CcSEcCtD
Clomipramine—Pain—Methotrexate—systemic scleroderma	6.59e-05	0.000177	CcSEcCtD
Clomipramine—Pruritus—Prednisone—systemic scleroderma	6.52e-05	0.000176	CcSEcCtD
Clomipramine—Feeling abnormal—Methotrexate—systemic scleroderma	6.35e-05	0.000171	CcSEcCtD
Clomipramine—Diarrhoea—Prednisone—systemic scleroderma	6.31e-05	0.00017	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.3e-05	0.00017	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—systemic scleroderma	6.12e-05	0.000165	CcSEcCtD
Clomipramine—Dizziness—Prednisone—systemic scleroderma	6.1e-05	0.000164	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—systemic scleroderma	6.09e-05	0.000164	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—systemic scleroderma	6.09e-05	0.000164	CcSEcCtD
Clomipramine—Vomiting—Prednisone—systemic scleroderma	5.86e-05	0.000158	CcSEcCtD
Clomipramine—Rash—Prednisone—systemic scleroderma	5.81e-05	0.000157	CcSEcCtD
Clomipramine—Dermatitis—Prednisone—systemic scleroderma	5.81e-05	0.000156	CcSEcCtD
Clomipramine—Headache—Prednisone—systemic scleroderma	5.78e-05	0.000156	CcSEcCtD
Clomipramine—Hypersensitivity—Methotrexate—systemic scleroderma	5.68e-05	0.000153	CcSEcCtD
Clomipramine—Asthenia—Methotrexate—systemic scleroderma	5.53e-05	0.000149	CcSEcCtD
Clomipramine—Nausea—Prednisone—systemic scleroderma	5.48e-05	0.000148	CcSEcCtD
Clomipramine—Pruritus—Methotrexate—systemic scleroderma	5.45e-05	0.000147	CcSEcCtD
Clomipramine—Diarrhoea—Methotrexate—systemic scleroderma	5.27e-05	0.000142	CcSEcCtD
Clomipramine—Dizziness—Methotrexate—systemic scleroderma	5.09e-05	0.000137	CcSEcCtD
Clomipramine—Vomiting—Methotrexate—systemic scleroderma	4.9e-05	0.000132	CcSEcCtD
Clomipramine—Rash—Methotrexate—systemic scleroderma	4.86e-05	0.000131	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—systemic scleroderma	4.85e-05	0.000131	CcSEcCtD
Clomipramine—Headache—Methotrexate—systemic scleroderma	4.83e-05	0.00013	CcSEcCtD
Clomipramine—Nausea—Methotrexate—systemic scleroderma	4.58e-05	0.000123	CcSEcCtD
